Artefenomel (also known as OZ439) is an investigational synthetic antimalarial agent designed for the treatment of malaria. It targets Plasmodium species, including drug-resistant strains, by inhibiting parasite growth. Currently in clinical development, it is studied for use in combination therapies to improve efficacy and combat resistance. As a research chemical with high purity (e.g., 98%), it is valuable for pharmacological studies and malaria research in endemic regions. Its rapid action and safety profile in trials position it as a promising tool in global malaria control efforts.